Recombinant multi-species WDR33 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WDR33 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD), which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes, including cell cycle progression, signal transduction, apoptosis, and gene regulation. This gene is highly expressed in testis and the protein is localized to the nucleus. This gene may play important roles in the mechanisms of cytodifferentiation and/or DNA recombination. Multiple alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
The Alternative Names of target: 1110001N06Rik,2310011G05Rik,2810021O11Rik,8430413N20Rik,NET14,WD repeat-containing protein 33,WD repeat-containing protein of 146 kDa,WDC146,WDR33,Wdr33,pre-mRNA 3' end processing protein WDR33

Target products collectionGo to WDR33 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP2277-Ag-1/ GM-Tg-hg-IP2277-Ag-2 Human WDR33 protein Human
GM-Tg-rg-IP2277-Ag-1/ GM-Tg-rg-IP2277-Ag-2 Rat WDR33 protein Rat
GM-Tg-mg-IP2277-Ag-1/ GM-Tg-mg-IP2277-Ag-2 Mouse WDR33 protein Mouse
GM-Tg-cynog-IP2277-Ag-1/ GM-Tg-cynog-IP2277-Ag-2 Cynomolgus/Rhesus macaque WDR33 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP2277-Ag-1/ GM-Tg-felg-IP2277-Ag-2 Feline WDR33 protein Feline
GM-Tg-cang-IP2277-Ag-1/ GM-Tg-cang-IP2277-Ag-2 Canine WDR33 protein Canine
GM-Tg-bovg-IP2277-Ag-1/ GM-Tg-bovg-IP2277-Ag-2 Bovine WDR33 protein Bovine
GM-Tg-equg-IP2277-Ag-1/ GM-Tg-equg-IP2277-Ag-2 Equine WDR33 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP2277-Ag-1/ GM-Tg-hg-IP2277-Ag-2; GM-Tg-rg-IP2277-Ag-1/ GM-Tg-rg-IP2277-Ag-2;
GM-Tg-mg-IP2277-Ag-1/ GM-Tg-mg-IP2277-Ag-2; GM-Tg-cynog-IP2277-Ag-1/ GM-Tg-cynog-IP2277-Ag-2;
GM-Tg-felg-IP2277-Ag-1/ GM-Tg-felg-IP2277-Ag-2; GM-Tg-cang-IP2277-Ag-1/ GM-Tg-cang-IP2277-Ag-2;
GM-Tg-bovg-IP2277-Ag-1/ GM-Tg-bovg-IP2277-Ag-2; GM-Tg-equg-IP2277-Ag-1/ GM-Tg-equg-IP2277-Ag-2
Products Name WDR33 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name WDR33
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WDR33 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.